Determining progress of chromosomal aberrations over time
AssigneeThe Chinese University of Hong Kong
InventorsYuk-Ming Dennis Lo, Kwan Chee Chan, Rossa Wai Kwun Chiu, Peiyong Jiang
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Chinese University of Hong Kong
InventorsYuk-Ming Dennis Lo, Kwan Chee Chan, Rossa Wai Kwun Chiu, Peiyong Jiang
Estimating the term…
Systems, apparatus, and methods are provided for determining aberrations in a biological sample from an organism. Biological samples including cell-free DNA fragments are analyzed to identify imbalances in chromosomal regions, e.g., due to deletions and/or amplifications in a tumor. Multiple loci are used for each chromosomal region. Imbalances can be used to diagnose a patient for cancer, prognosticate a patient with cancer, or to detect the presence or monitor progress of a premalignant condition. The severity of an imbalance as well as the number of regions exhibiting an imbalance can be used. A systematic analysis of non-overlapping segments of a genome can provide a general screening tool for a sample. Additionally, a patient can be tested over time to track severity of each of one or more chromosomal regions and a number of chromosomal regions to enable screening and prognosticating, as well as monitoring of progress (e.g. after treatment).
A method of determining a progress of chromosomal aberrations in an organism using biological samples including cell-free nucleic acid molecules originating from normal cells and potentially from cells associated with a disease, the method comprising:
A computer program product comprising a non-transitory computer readable medium storing a plurality of instructions for controlling a computer system coupled to a sequencer to perform an operation for determining a progress of chromosomal aberrations in an organism using biological samples including cell-free nucleic acid molecules originating from normal cells and potentially from cells associated with a disease, the operation comprising:
A computer system for determining a progress of chromosomal aberrations in an organism using biological samples including cell-free nucleic acid molecules originating from normal cells and potentially from cells associated with a disease, the computer system coupled to a sequencer and comprising computer processors configured for:
Dependencies are inferred from the claim text.